Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Valion Bio (TIVC) Return on Equity (2021 - 2025)

Valion Bio has reported Return on Equity over the past 5 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Equity rose 2.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, up 2.0%, while the annual FY2024 figure was 0.02%, 4.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.01% at Valion Bio, up from 0.02% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.01% in Q1 2022 and troughed at 0.03% in Q1 2024.
  • A 5-year average of 0.02% and a median of 0.02% in 2025 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: fell -2bps in 2023 and later grew 2bps in 2025.
  • Year by year, Return on Equity stood at 0.02% in 2021, then tumbled by -31bps to 0.02% in 2022, then rose by 18bps to 0.02% in 2023, then decreased by -21bps to 0.02% in 2024, then surged by 72bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for TIVC at 0.01% in Q4 2025, 0.02% in Q3 2025, and 0.02% in Q2 2025.